The Role of Roquette’s KLEPTOSE® HPβCD in the Fight against Coronavirus

Roquette has identified that its KLEPTOSE® hydroxypropyl beta-cyclodextrin (HPβCD) product, a functional excipient and a specialty active pharmaceutical ingredient (API), may be effective to help the joint efforts of the scientific and pharmaceutical communities working on treating and preventing new emerging viruses such as the coronavirus.  

HPβCD can effectively act as a safe, enabling excipient for solubility enhancement of antiviral drugs, stability improvement of therapeutic monoclonal antibodies, and as a vaccine adjuvant.